Woods R J, Prueckner S, Safar P, Takasu A, Tisherman S A, Jackson E K, Radovsky A, Kochanek P, Behringer W, Stezoski S W, Hans R
Safar Center for Resuscitation Research and the Department of Anesthesiology/Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA 15260, USA.
Resuscitation. 2000 Mar;44(1):47-59. doi: 10.1016/s0300-9572(99)00164-1.
Most trauma cases with rapid exsanguination to cardiac arrest (CA) in the field, as well as many cases of normovolemic sudden cardiac death are 'unresuscitable' by standard cardiopulmonary-cerebral resuscitation (CPCR). We are presenting a dog model for exploring pharmacological strategies for the rapid induction by aortic arch flush of suspended animation (SA), i.e. preservation of cerebral viability for 15 min or longer. This can be extended by profound hypothermic circulatory arrest of at least 60 min, induced and reversed with (portable) cardiopulmonary bypass (CPB). SA is meant to buy time for transport and repair during pulselessness, to be followed by delayed resuscitation to survival without brain damage. This model with exsanguination over 5 min to CA of 15-min no-flow, is to evaluate rapid SA induction by aortic flush of normal saline solution (NSS) at room temperature (24 degrees C) at 2-min no-flow. This previously achieved normal functional recovery, but with histologic brain damage. We hypothesized that the addition of adenosine would achieve recovery with no histologic damage, because adenosine delays energy failure and helps repair brain injury. This dog model included reversal of 15-min no-flow with closed-chest CPB, controlled ventilation to 20 h, and intensive care to 72 h. Outcome was evaluated by overall performance, neurologic deficit, and brain histologic damage. At 2 min of CA, 500 ml of NSS at 24 degrees C was flushed (over 1 min) into the brain and heart via an aortic balloon catheter. Controls (n=5) received no drug. The adenosine group (n=5) received 2-chloro-adenosine (long acting adenosine analogue), 30 mg in the flush solution, and, after reperfusion, adenosine i.v. over 12 h (210 microg/kg per min for 3 h, 140 microg/kg per min for 9 h). The 24 degrees C flush reduced tympanic membrane temperature (T(ty)) within 2 min of CA from 37.5 to approximately 36.0 degrees C in both groups. At 72 h, final overall performance category (OPC) 1 (normal) was achieved by all ten dogs of the two groups. Final neurologic deficit scores (NDS; 0-10% normal, 100% brain death) were 5+/-3% in the control group versus 6+/-5% in the adenosine group (NS). Total brain histologic damage scores (HDS) at 72 h were 74+/-9 (64-80) in the control group versus 68+/-19 (40-88) in the adenosine group (NS). In both groups, ischemic neurons were as prevalent in the basal ganglia and neocortex as in the cerebellum and hippocampus. The mild hypothermic aortic flush protocol is feasible in dogs. The adenosine strategy used does not abolish the mild histologic brain damage.
大多数在现场因快速失血导致心脏骤停(CA)的创伤病例,以及许多正常血容量性心源性猝死病例,通过标准的心肺脑复苏(CPCR)是“无法复苏的”。我们正在展示一种犬类模型,用于探索通过主动脉弓冲洗快速诱导假死(SA)的药理学策略,即保持脑存活能力15分钟或更长时间。这可以通过至少60分钟的深度低温循环骤停来延长,通过(便携式)体外循环(CPB)诱导并逆转。SA旨在为无脉期间的转运和修复争取时间,随后进行延迟复苏以实现无脑损伤存活。这个在5分钟内失血至15分钟无血流CA的模型,是为了评估在室温(24摄氏度)下2分钟无血流时通过主动脉冲洗生理盐水溶液(NSS)快速诱导SA的情况。此前这实现了正常功能恢复,但存在组织学脑损伤。我们假设添加腺苷将实现无组织学损伤的恢复,因为腺苷可延迟能量衰竭并有助于修复脑损伤。这个犬类模型包括通过闭胸CPB逆转15分钟无血流、控制通气20小时以及重症监护72小时。通过总体表现、神经功能缺损和脑组织学损伤来评估结果。在CA 2分钟时,将500毫升24摄氏度的NSS(在1分钟内)通过主动脉球囊导管冲洗入脑和心脏。对照组(n = 5)未接受药物。腺苷组(n = 5)在冲洗液中接受2 - 氯腺苷(长效腺苷类似物)30毫克,再灌注后静脉注射腺苷12小时(3小时内210微克/千克每分钟,9小时内140微克/千克每分钟)。两组在CA 2分钟内,24摄氏度冲洗使鼓膜温度(T(ty))从37.5摄氏度降至约36.0摄氏度。在72小时时,两组的所有十只犬均达到最终总体表现类别(OPC)1(正常)。最终神经功能缺损评分(NDS;0 - 10%正常,100%脑死亡)在对照组为5±3%,在腺苷组为6±5%(无显著差异)。72小时时总的脑组织学损伤评分(HDS)在对照组为74±9(6